Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Fanconi Anemia

Blood & Immune

Fanconi Anemia (FA) Clinical Trials and Treatments

Also called FA, hereditary panmyelopathy, clastogenic anemia, Fanconi Anaemia

Fanconi anemia (FA) is a rare inherited bone marrow failure syndrome characterized by severe cellular hypersensitivity to DNA crosslinking agents and progressive pancytopenia. Caused by mutations in genes encoding proteins involved in DNA repair (particularly homologous recombination repair and DNA interstrand crosslink repair), FA comprises 22+ complementation groups (FA-A through FA-W) with distinct genetic and clinical features.

In plain words, Fanconi anemia is a rare inherited condition in which the bone marrow slowly stops making enough blood cells. People with it can have tiredness, bleeding and infections, and they have a much higher chance of certain cancers.

Get an email when new Fanconi Anemia trials open or the FDA decides. Get alerts

Fanconi Anemia

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 9 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Fanconi Anemia yet.

Fanconi Anemia has no FDA-approved medicines, 16 open or active clinical trials (13 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

Each date is the day a change was posted. Open an item to see where things stand now.

More about Fanconi Anemia

The hallmark diagnostic feature is chromosomal breakage induced by diepoxybutane (DEB) or mitomycin C (MMC) testing. Pathophysiology involves impaired DNA crosslink repair, resulting in genomic instability and accumulation of damage in proliferating hematopoietic cells.

Keep reading about Fanconi Anemia

Patients develop progressive bone marrow failure with pancytopenia typically by second decade of life. About 75% have physical abnormalities including short stature, skeletal defects (thumb hypoplasia, radial ray defects, syndactyly), microcephaly, cleft lip/palate, and cardiac, renal, or urogenital anomalies.

Most critically, FA patients have exponentially increased cancer risk with approximately 75% developing solid tumors or hematologic malignancies (acute myeloid leukemia, myelodysplastic syndrome, squamous cell carcinomas) by age 50. Gender ratios approximately equal. Prognosis without transplantation guarded.

What are the symptoms of Fanconi Anemia?

These are common symptoms of Fanconi Anemia, and how strong they are varies from person to person.

  • Anemia, thrombocytopenia, neutropenia by age 10
  • Progressive bone marrow failure
  • Physical abnormalities (short stature, thumb/radial defects)
  • Increased bleeding and infections
  • Developmental delay in some forms
  • Extreme leukemia and solid tumor risk

Who gets Fanconi Anemia?

Typically manifests in first two decades of life with median diagnosis age 7 years. Affects males and females equally. Autosomal recessive inheritance in most types (FA-A most common, ~70% of cases); X-linked inheritance in rare FA-B type.

More common in certain ethnic populations including Ashkenazi Jewish, Hispanic, and South Asian populations. Carrier frequency for FA-A mutations higher in these populations. No geographic clustering beyond ethnic variation. Consanguinity increases incidence.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Fanconi Anemia

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Fanconi Anemia resources

Reputable organizations and medical references for learning more about Fanconi Anemia, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Fanconi Anemia

Use this Fanconi Anemia clinical trial finder to see the 13 studies recruiting patients and 3 not yet recruiting in the United States and worldwide, with eligibility criteria in plain English. Of these, 9 test a treatment and 7 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

16 active trials worldwide
Filter:
Sort:
Not yet recruitingObservational study, no treatment givenRecently updatedNCT07005297

Clinical Genetics Branch Eligibility Screening Survey

Sponsor: National Cancer Institute (NCI)

Background:

Ages 1 Year to 99 Years1 location
Expected to start Nov 2026Updated yesterdayEst. Jan 2035 (~8y 1m)
RecruitingObservational study, no treatment givenRecently updatedNCT00027274

Cancer in Inherited Bone Marrow Failure Syndromes

Sponsor: National Cancer Institute (NCI)

Background:

A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders.

Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers.

Ages 1 Day to 100 Years2 locations
Started Nov 2001Updated 6 days agoCompletion date not listed
RecruitingObservational study, no treatment givenRecently updatedNCT05687149

Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia

Sponsor: National Cancer Institute (NCI)

Background:

Ages 8 Years to 90 Years1 location
Started Mar 2023Updated 1 week agoEst. Dec 2035 (~9y 1m)
RecruitingTreatment trialPhase 1Recently updatedNCT07901959

Safety and Tolerability of Metformin and Naproxen for Cancer Prevention in Fanconi Anemia

Intervention: Metformin, Naproxen Sodium

Sponsor: Rockefeller University

Finding effective ways to slow down or prevent the development of cancer in people with Fanconi anemia (FA) is a critical medical priority. Individuals with FA are at dramatically higher risk of developing aggressive cancers, particularly of the head and neck, and these cancers a...

Ages 18 Years+2 locations
Expected to start Oct 2026Updated 3 weeks agoEst. Oct 2030 (~3y 11m)
RecruitingObservational study, no treatment givenRecently updatedNCT07877727

Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data

Sponsor: Istituto Giannina Gaslini

A non-profit, translational, prospective and retrospective study.

Patients will be enrolled according to the procedures described in the protocol, and samples will be processed and analyzed as specified in the protocol.

Ages 28 Days to 65 Years4 locations
Started May 2025Updated 1 month agoEst. Dec 2026 (~1 month)
Find Fanconi Anemia trials near you, ranked by distance →
Active trial locations10 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+2 more

Trial Pipeline

Jan 2021 to Nov 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Fanconi Anemia trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Fanconi Anemia foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Fanconi Anemia patient communities

Facebook groups, Reddit communities and YouTube channels where Fanconi Anemia patients, caregivers and advocacy groups talk.

Companies developing Fanconi Anemia treatments

Drugmakers that list Fanconi Anemia in their rare disease portfolio, 1 in all.

Questions people ask about Fanconi Anemia